Biotechnology From Molecule To Medicine

You’re excited by the opportunities your new compound presents. However, as it advances through each stage of the pre clinical/clinical development process, the cost and complexities continue to increase. These challenges escalate when you go to market.

Recognizing that the needs of emerging biotech companies are unique, we created a specialized team dedicated exclusively to biotechs. That means taking your project to heart — developing a sense of commitment, ownership and pride in overcoming the challenges that inevitably develop during any complex project.

It means getting the job done, and done well, whatever it takes. We’ve walked in your shoes. Most of our senior team members and experts have worked at biopharma start-ups or emerging companies and played key roles in their success. IQnovate shares your sense of urgency — we understand your need to meet your CCDP and LCCDP milestones.

Through these experts, we can design programs to bridge your science with business. Converting your compound into a pharmaceutical – generating premium value for all stakeholders.